Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.jupiterhospital.com | |
Market Cap | 7,251.60 Cr. | |
Enterprise Value(EV) | 6,932.76 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 11.12 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 99.47 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 60.78 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 164.88 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 6.71 | Calculated using Price: 1,106.00 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 6.56 Cr. | 65,566,022 Shares |
FaceValue | 10 | |
About Jupiter Life Line Hospitals Ltd. | ||
The company is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare providers. |
1 Day |
|
+4.65% |
1 Week |
|
+9.83% |
1 Month |
|
+7.65% |
3 Month |
|
|
6 Month |
|
|
1 Year |
|
|
2 Year |
|
|
5 Year |
|
|
10 Year |
|
4 years | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 12.52 | -0.97 | 19.27 | 22.18 | |
Return on Capital Employed (%) | 11.52 | 6.91 | 16.66 | 21.07 | |
Return on Assets (%) | 4.91 | -0.33 | 6.01 | 7.70 |
Particulars | 5 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 237 | 239 | 294 | 366 | 1,081 | |
Non Curr. Liab. | 263 | 452 | 497 | 489 | 2 | |
Curr. Liab. | 103 | 96 | 123 | 132 | 143 | |
Minority Int. | 0 | 7 | -5 | -2 | 0 | |
Equity & Liab. | 603 | 794 | 909 | 986 | 1,226 | |
Non Curr. Assets | 447 | 681 | 728 | 776 | 780 | |
Curr. Assets | 156 | 113 | 180 | 209 | 446 | |
Misc. Exp. not W/O | ||||||
Total Assets | 603 | 794 | 909 | 986 | 1,226 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 463 | 486 | 733 | 893 | |
Other Income | 3 | 4 | 4 | 10 | |
Total Income | 466 | 490 | 737 | 903 | |
Total Expenditure | -382 | -419 | -580 | -691 | |
PBIDT | 84 | 71 | 157 | 212 | |
Interest | -26 | -39 | -44 | -42 | |
Depreciation | -26 | -31 | -36 | -39 | |
Taxation | -3 | -4 | -26 | -56 | |
Exceptional Items | 0 | -2 | |||
PAT | 30 | -2 | 51 | 73 | |
Minority Interest | |||||
Share Associate | |||||
Other Related Items | |||||
Consolidated Net Profit | 30 | -2 | 51 | 73 | |
Adjusted EPS | 6 | 0 | 10 | 13 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 74 | 123 | 137 | 176 | |
Cash Fr. Inv. | -43 | -296 | -85 | -94 | |
Cash Fr. Finan. | -32 | 185 | 32 | -51 | |
Net Change | -1 | 12 | 84 | 31 | |
Cash & Cash Eqvt | 7 | 19 | 103 | 134 |
Tue, 21 Nov 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript Q2 & H1 FY24 Earnings Conference Call- Transcript |
Wed, 15 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Audio Link of Analyst/ Investor Conference Call for Q2 &H1 FY24 |
Wed, 15 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Tue, 28 Nov 2023 |
|
|
|
Fri, 24 Nov 2023 |
|
|